Veracyte Inc at Needham Healthcare Conference Transcript
Hi, everyone. In the interest of time, I'll get us started this morning. Thank you, everyone, for joining us. This is the second day of the Needham 18th Annual Healthcare Conference. My name is Steve Unger. I'm the life science tools and diagnostics analyst here at Needham, and it is certainly my pleasure to introduce our first company today in our cancer diagnostics track. This is Veracyte. Ticker is VCYX and -- VCYT, sorry, sorry.
And with us today is Bonnie Anderson, Chairman and CEO; Keith Kennedy, Chief Financial Officer; and Angie McCabe, Director of Investor Relations. Bonnie is going to provide a quick -- an overview of the company, and if there's time available, we'll open it up for some questions in the room.
And with that, I'm going to hand it over to Bonnie.
Thank you, Steve. I'd like to start by thanking Needham for inviting us to present at the conference this year, and it's
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |